Skip to main content
Top
Published in: CEN Case Reports 3/2021

01-08-2021 | Autopsy | Case Report

Polyvisceral polycystic disease: a case study and review

Authors: K. Indumathi, G. Bhavani, K. Sudha, G. Srinivasaraman, R. Manjunathan

Published in: CEN Case Reports | Issue 3/2021

Login to get access

Abstract

Polycystic kidney disease (PKD) occurs in one per 20,000 births. Presence of cysts in other organs like adrenal, liver and bladder is even rarer. On reviewing the literature, there is evidence of PKD occurring in conjunction with polycystic liver disease but cysts in multiple viscera are, so far, not reported. A fetal autopsy of a 36-week fetus showed the presence of multiple cysts in the kidney, liver, adrenal and bladder. Further histopathology reports confirmed the diagnosis of polycystic kidney disease. The history of a previous intrauterine death, of another child at 28-week gestation, suggests the presence of familial type. Serial prenatal ultrasonogram did not detect the abnormalities, emphasizing the important role of fetal autopsy in a case with an incomplete obstetric history. The diagnosis of a fetal abnormality aids to counselling the parents to be aware of possible recurrences in new pregnancies.
Literature
1.
go back to reference Khong YT, Malcomson RDG, editors. Keeling’s fetal and neonatal pathology. 5th ed. New York: Springer International Publishing; 2015. Khong YT, Malcomson RDG, editors. Keeling’s fetal and neonatal pathology. 5th ed. New York: Springer International Publishing; 2015.
2.
go back to reference Cai M, Lin N, Su L, Wu X, Xie X, Li Y, Chen X, Dai Y, Lin Y, Huang H, Xu L. Detection of copy number disorders associated with congenital anomalies of the kidney and urinary tract in fetuses via single nucleotide polymorphism arrays. J Clin Lab Anal. 2020;34(1):e23025.CrossRef Cai M, Lin N, Su L, Wu X, Xie X, Li Y, Chen X, Dai Y, Lin Y, Huang H, Xu L. Detection of copy number disorders associated with congenital anomalies of the kidney and urinary tract in fetuses via single nucleotide polymorphism arrays. J Clin Lab Anal. 2020;34(1):e23025.CrossRef
3.
go back to reference Chakraborty S, McHugh K. Cystic diseases of the kidney in children. Imaging. 2005;17(1):69–75.CrossRef Chakraborty S, McHugh K. Cystic diseases of the kidney in children. Imaging. 2005;17(1):69–75.CrossRef
4.
go back to reference Khare A, Krishnappa V, Kumar D, Raina R. Neonatal renal cystic diseases. J Matern Fetal Neonatal Med. 2018;31(21):2923–9.CrossRef Khare A, Krishnappa V, Kumar D, Raina R. Neonatal renal cystic diseases. J Matern Fetal Neonatal Med. 2018;31(21):2923–9.CrossRef
5.
6.
go back to reference Kabaalioğlu A, MacLennan GT. Cystic diseases of the kidney. In: Dogra VS, MacLennan GT, editors. Genitourinary radiology: kidney, bladder and urethra: the pathologic basis. New York: Springer; 2013. p. 95–119.CrossRef Kabaalioğlu A, MacLennan GT. Cystic diseases of the kidney. In: Dogra VS, MacLennan GT, editors. Genitourinary radiology: kidney, bladder and urethra: the pathologic basis. New York: Springer; 2013. p. 95–119.CrossRef
7.
go back to reference Kwatra S, Krishnappa V, Mhanna C, Murray T, Novak R, Sethi SK, Kumar D, Raina R. Cystic diseases of childhood: a review. Urology. 2017;110:184–91.CrossRef Kwatra S, Krishnappa V, Mhanna C, Murray T, Novak R, Sethi SK, Kumar D, Raina R. Cystic diseases of childhood: a review. Urology. 2017;110:184–91.CrossRef
8.
go back to reference Cassidy A, Herrick C, Norton ME, Ursell PC, Vargas J, Kerns JL. How does fetal autopsy after pregnancy loss or termination for anomalies and other complications change recurrence risk? Am J Perinatol Rep. 2019;09(1):e30–5.CrossRef Cassidy A, Herrick C, Norton ME, Ursell PC, Vargas J, Kerns JL. How does fetal autopsy after pregnancy loss or termination for anomalies and other complications change recurrence risk? Am J Perinatol Rep. 2019;09(1):e30–5.CrossRef
9.
go back to reference Bergmann C. ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies. Pediatr Nephrol (Berlin, Germany). 2015;30(1):15–30.CrossRef Bergmann C. ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies. Pediatr Nephrol (Berlin, Germany). 2015;30(1):15–30.CrossRef
10.
go back to reference Boyd PA, Tondi F, Hicks NR, Chamberlain PF. Autopsy after termination of pregnancy for fetal anomaly: retrospective cohort study. BMJ (Clin Res Ed). 2004;328(7432):137.CrossRef Boyd PA, Tondi F, Hicks NR, Chamberlain PF. Autopsy after termination of pregnancy for fetal anomaly: retrospective cohort study. BMJ (Clin Res Ed). 2004;328(7432):137.CrossRef
12.
go back to reference Husson H, Manavalan P, Akmaev VR, et al. New insights into ADPKD molecular pathways using combination of SAGE and microarray technologies. Genomics. 2004;84(3):497–510.CrossRef Husson H, Manavalan P, Akmaev VR, et al. New insights into ADPKD molecular pathways using combination of SAGE and microarray technologies. Genomics. 2004;84(3):497–510.CrossRef
14.
go back to reference Garel J, Lefebvre M, Cassart M, et al. Prenatal ultrasonography of autosomal dominant polycystic kidney disease mimicking recessive type: case series. Pediatr Radiol. 2019;49(7):906–12.CrossRef Garel J, Lefebvre M, Cassart M, et al. Prenatal ultrasonography of autosomal dominant polycystic kidney disease mimicking recessive type: case series. Pediatr Radiol. 2019;49(7):906–12.CrossRef
16.
go back to reference Schieren G, Rumberger B, Klein M, et al. Gene profiling of polycystic kidneys. Nephrol Dial Transplant. 2006;21(7):1816–24.CrossRef Schieren G, Rumberger B, Klein M, et al. Gene profiling of polycystic kidneys. Nephrol Dial Transplant. 2006;21(7):1816–24.CrossRef
17.
go back to reference Bergmann C, von Bothmer J, Brüchle NO, et al. Mutations in multiple PKD genes may explain early and severe polycystic kidney disease. J Am Soc Nephrol. 2011;22(11):2047–56.CrossRef Bergmann C, von Bothmer J, Brüchle NO, et al. Mutations in multiple PKD genes may explain early and severe polycystic kidney disease. J Am Soc Nephrol. 2011;22(11):2047–56.CrossRef
18.
go back to reference Nakagawa S, Furuichi K, Sagara A, et al. An autopsy case of vertebrobasilar dolichoectasia under hemodialysis due to autosomal dominant polycystic kidney disease. CEN Case Rep. 2015;5(1):51–5.CrossRef Nakagawa S, Furuichi K, Sagara A, et al. An autopsy case of vertebrobasilar dolichoectasia under hemodialysis due to autosomal dominant polycystic kidney disease. CEN Case Rep. 2015;5(1):51–5.CrossRef
19.
go back to reference Bhandari BJ, Patil RK, Kittur SK. Renal adysplasia in fetus: a rare autopsy case report. APALM. 2017;4(6):C172-175.CrossRef Bhandari BJ, Patil RK, Kittur SK. Renal adysplasia in fetus: a rare autopsy case report. APALM. 2017;4(6):C172-175.CrossRef
20.
go back to reference Chebib FT, Hogan MC. Extrarenal manifestations of autosomal dominant polycystic kidney disease: polycystic liver disease. In: Cowley BD Jr, Bissler JJ, editors. Polycystic kidney disease: translating mechanisms into therapy. New York: Springer; 2018. p. 171–95.CrossRef Chebib FT, Hogan MC. Extrarenal manifestations of autosomal dominant polycystic kidney disease: polycystic liver disease. In: Cowley BD Jr, Bissler JJ, editors. Polycystic kidney disease: translating mechanisms into therapy. New York: Springer; 2018. p. 171–95.CrossRef
21.
go back to reference Atim T, Mukhtar A. Giant adrenal cyst in a young female patient: a case report. Afr J Urol. 2016;22(2):83–5.CrossRef Atim T, Mukhtar A. Giant adrenal cyst in a young female patient: a case report. Afr J Urol. 2016;22(2):83–5.CrossRef
22.
go back to reference Ali Z, Tariq H, Rehman U. Endothelial cysts of adrenal gland. J Coll Physicians Surg Pak. 2019;29(6):S16–7.CrossRef Ali Z, Tariq H, Rehman U. Endothelial cysts of adrenal gland. J Coll Physicians Surg Pak. 2019;29(6):S16–7.CrossRef
Metadata
Title
Polyvisceral polycystic disease: a case study and review
Authors
K. Indumathi
G. Bhavani
K. Sudha
G. Srinivasaraman
R. Manjunathan
Publication date
01-08-2021
Publisher
Springer Singapore
Published in
CEN Case Reports / Issue 3/2021
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-021-00582-1

Other articles of this Issue 3/2021

CEN Case Reports 3/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.